09/08/2025
🌟 Surgeon Spotlight 🌟
Exciting Breakthrough in Eye Care! 👁
We are thrilled to highlight the exceptional Dr. Tomasz Stryjewski, a Harvard trained retina specialist, co founder and Chief Scientific Officer at Pykus Therapeutics, and a board-certified vitreoretinal surgeon here at Orchard Surgical Center.
Forbes Magazine recently featured his team’s novel innovation: PYK 2101, a next-generation biodegradable retinal sealant that could completely transform recovery after retinal detachment surgery.
This innovative "retinal patch" could eliminate the need for gas bubbles and days of face-down recovery. In early clinical trials, patients experienced visual recovery in days—not weeks—with a 91% single-surgery success rate and no serious side effects.
Though still in the clinical phase, PYK-2101 could mark a major leap forward in patient comfort and care.
Read Full Article:
https://www.forbes.com/sites/milletienne/2025/05/05/next-gen-sealant-speeds-recovery-after-retinal-detachment-study-finds/
